Log in

Relevant bibliographies by topics / Pediatric Cancer Susceptibility

Contents

Journal articles
Book chapters
Conference papers

Academic literature on the topic 'Pediatric Cancer Susceptibility'

Author: Grafiati

Published: 3 June 2025

Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Pediatric Cancer Susceptibility.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Pediatric Cancer Susceptibility"

1

Plon, Sharon E., and Katherine Nathanson. "Inherited Susceptibility for Pediatric Cancer." Cancer Journal 11, no. 4 (2005): 255–67. http://dx.doi.org/10.1097/00130404-200507000-00002.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

McReynolds, Lisa J., and Sharon A. Savage. "Pediatric leukemia susceptibility disorders: manifestations and management." Hematology 2017, no. 1 (2017): 242–50. http://dx.doi.org/10.1182/asheducation-2017.1.242.

Full text

Abstract:

Abstract The clinical manifestations of inherited susceptibility to leukemia encompass a wide phenotypic range, including patients with certain congenital anomalies or early-onset myelodysplastic syndrome (MDS) and some with no obvious medical problems until they develop leukemia. Leukemia susceptibility syndromes occur as a result of autosomal dominant, autosomal recessive, or X-linked recessive inheritance, or de novo occurrence, of germline pathogenic variants in DNA repair, ribosome biogenesis, telomere biology, hematopoietic transcription factors, tumor suppressors, and other critical cel

APA, Harvard, Vancouver, ISO, and other styles

3

Kennedy, Richard D., and Alan D. D'Andrea. "DNA Repair Pathways in Clinical Practice: Lessons From Pediatric Cancer Susceptibility Syndromes." Journal of Clinical Oncology 24, no. 23 (2006): 3799–808. http://dx.doi.org/10.1200/jco.2005.05.4171.

Full text

Abstract:

Human cancers exhibit genomic instability and an increased mutation rate due to underlying defects in DNA repair. Cancer cells are often defective in one of six major DNA repair pathways, namely: mismatch repair, base excision repair, nucleotide excision repair, homologous recombination, nonhomologous endjoining and translesion synthesis. The specific DNA repair pathway affected is predictive of the kinds of mutations, the tumor drug sensitivity, and the treatment outcome. The study of rare inherited DNA repair disorders, such as Fanconi anemia, has yielded new insights to drug sensitivity and

APA, Harvard, Vancouver, ISO, and other styles

4

Godinez Paredes, Jesica M., Claudia Garrido, Patricia Calderón, et al. "Abstract 2273: The spectrum of germline cancer gene mutations in Central American pediatric cancer." Cancer Research 85, no. 8_Supplement_1 (2025): 2273. https://doi.org/10.1158/1538-7445.am2025-2273.

Full text

Abstract:

Abstract Pediatric cancers are a diverse set of both hematologic and solid malignancies. Approximately 5% of pediatric cancer cases are caused by known genetic conditions, but little is known about genetic susceptibility in Central American children. Most pediatric leukemia and lymphoma cases have high response and cure rates, and many solid malignancies have better outcomes than similar adult cancers. We evaluated the germline genetic variation of pediatric solid tumor cases in Guatemala and Nicaragua in reference hospitals, capturing most of the cancer cases nationwide. We performed exome se

APA, Harvard, Vancouver, ISO, and other styles

5

Cornel, Annelisa M., Loutje van der Sman, Jip T. van Dinter, et al. "Targeting pediatric cancers via T-cell recognition of the monomorphic MHC class I-related protein MR1." Journal for ImmunoTherapy of Cancer 12, no. 3 (2024): e007538. http://dx.doi.org/10.1136/jitc-2023-007538.

Full text

Abstract:

Human leukocyte antigen (HLA) restriction of conventional T-cell targeting introduces complexity in generating T-cell therapy strategies for patients with cancer with diverse HLA-backgrounds. A subpopulation of atypical, major histocompatibility complex-I related protein 1 (MR1)-restricted T-cells, distinctive from mucosal-associated invariant T-cells (MAITs), was recently identified recognizing currently unidentified MR1-presented cancer-specific metabolites. It is hypothesized that the MC.7.G5 MR1T-clone has potential as a pan-cancer, pan-population T-cell immunotherapy approach. These cells

APA, Harvard, Vancouver, ISO, and other styles

6

Nirmalkar, Nikita, Ishani Arora, Vaishnavi H. Mishra, Gulshan R. Bandre, and Yugeshwari R. Tiwade. "Genetic Susceptibility and Treatment Personalization in Acute Lymphoblastic Leukemia: A Comprehensive Review of Genetic Susceptibility and Targeted Therapies." Journal of Applied Hematology 15, no. 3 (2024): 163–68. http://dx.doi.org/10.4103/joah.joah_40_24.

Full text

Abstract:

Abstract Acute lymphoblastic leukemia (ALL) in children is a complicated and heterogeneous disease impacted by various genetic susceptibility factors. The significance of genetic testing in pediatric ALL diagnosis and management, the role of minimal residual disease (MRD) monitoring, and ethical issues and problems in pediatric genetic testing are discussed in this narrative review. It also looks ahead to the future of genetic susceptibility research, focusing on data integration, artificial intelligence-driven insights, and the possible finding of novel treatment targets. We hope to provide a

APA, Harvard, Vancouver, ISO, and other styles

7

Liu, Zan, Zhenghui Xiao, Ming Li, et al. "Association Between Arg72Pro Polymorphism in TP53 and Malignant Abdominal Solid Tumor Risk in Hunan Children." Cancer Control 28 (January 1, 2021): 107327482110048. http://dx.doi.org/10.1177/10732748211004880.

Full text

Abstract:

Pediatric solid tumors are heterogeneous and comprise various histological subtypes. TP53, a tumor suppressor, orchestrates the transcriptional activation of anti-cancer genes. The gene coding for this protein is highly polymorphic, and its mutations are associated with cancer development. The Arg72Pro polymorphism in TP53 has been associated with susceptibility to various types of cancer. Here, in this hospital-based study, we evaluated the association of this polymorphism with susceptibility toward malignant abdominal solid tumors in children in the Hunan province of China. We enrolled 162 p

APA, Harvard, Vancouver, ISO, and other styles

8

Patenaude, A. F., L. Basili, D. L. Fairclough, and F. P. Li. "Attitudes of 47 mothers of pediatric oncology patients toward genetic testing for cancer predisposition." Journal of Clinical Oncology 14, no. 2 (1996): 415–21. http://dx.doi.org/10.1200/jco.1996.14.2.415.

Full text

Abstract:

PURPOSE To assess attitudes toward testing for cancer susceptibility genes, we interviewed mothers of pediatric oncology patients about their cancer causation theories, interest in hypothetical predisposition testing for themselves and their healthy children, and anticipated impact of testing. PATIENTS AND METHODS The subjects were 47 mothers of two or more living children, one of whom was 6 to 24 months postdiagnosis of cancer. Potential risks and benefits of hypothetical genetic predisposition testing for cancer susceptibility were described. A semistructured interview assessed the following

APA, Harvard, Vancouver, ISO, and other styles

9

Kara, Buket, and Yavuz Koksal. "Pediatric Lymphoma and Solid Tumors Associated With Cancer Susceptibility Syndromes." Journal of Pediatric Hematology/Oncology 42, no. 7 (2020): 438–45. http://dx.doi.org/10.1097/mph.0000000000001798.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Hadi, Dalal Abbas. "Spectrum of Bacterial Infection and Antibiotic Susceptibility Profile among Clinical Samples of Febrile Pediatric Cancer Patients under Chemotherapy." International Journal of Psychosocial Rehabilitation 24, no. 5 (2020): 1189–203. http://dx.doi.org/10.37200/ijpr/v24i5/pr201794.

Full text

APA, Harvard, Vancouver, ISO, and other styles

More sources

Book chapters on the topic "Pediatric Cancer Susceptibility"

1

Sherborne, Amy L., and Richard S. Houlston. "Risk of Childhood Acute Lymphoblastic Leukemia: Identification of Inherited Susceptibility." In Pediatric Cancer, Volume 4. Springer Netherlands, 2013. http://dx.doi.org/10.1007/978-94-007-6591-7_11.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Kunkle, Brian, David Sandberg, Prasanna Jayakar, Quentin Felty, and Deodutta Roy. "Gene–Environment Interaction and Susceptibility to Pediatric Brain Tumors." In Environmental Factors, Genes, and the Development of Human Cancers. Springer New York, 2010. http://dx.doi.org/10.1007/978-1-4419-6752-7_9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Patenaude, Andrea Farkas, and Katherine A. Schneider. "Genetic Issues." In Comprehensive Handbook of Childhood Cancer and Sickle Cell Disease. Oxford University Press, 2006. http://dx.doi.org/10.1093/oso/9780195169850.003.0028.

Full text

Abstract:

The hallmark of genetic medicine is that medical concerns of one individual are germane not only for that person, but also for their offspring and future generations. Pediatric cancer patients, survivors of childhood cancers, their parents, and their siblings all have concerns that are likely to be increasingly affected by advances in genetics. It has been estimated that between 10% and 15% of pediatric cancers are either hereditary or familial in origin (Quesnel & Malkin, 1997). Advances in genetics will help identify pediatric cancers that have a hereditary origin as well as genetic synd

APA, Harvard, Vancouver, ISO, and other styles

4

Farnaz, Dr Huma, and Dr Dipanshu Aggarwal. "CANCER CHRONICLES: UNDERSTANDING, TREATING, AND OVERCOMING: NARRATIVE REVIEW." In Futuristic Trends in Medical Sciences Volume 3 Book 20. Iterative International Publisher, Selfypage Developers Pvt Ltd, 2024. http://dx.doi.org/10.58532/v3bfms20p1ch8.

Full text

Abstract:

This abstract delves into the nuanced concept of health, focusing on the pivotal stages of treatment planning and the profound implications of cancer within this context. Health, encompassing both mental and physical well-being, stands as a cornerstone of human existence. The article underscores the initial significance of delineating treatment objectives to devise effective strategies that target the fundamental causes of health issues and foster sustainable wellness. The judicious selection of treatment regimens necessitates a holistic understanding of the underlying ailment and the distinct

APA, Harvard, Vancouver, ISO, and other styles

5

Swain, Nicole F., and Scott W. Powers. "Pain Management of Sickle Cell Disease." In Comprehensive Handbook of Childhood Cancer and Sickle Cell Disease. Oxford University Press, 2006. http://dx.doi.org/10.1093/oso/9780195169850.003.0036.

Full text

Abstract:

Acute and chronic pain episodes are common experiences for many individuals living with sickle cell disease (SCD). The management of pain related to SCD is primary palliative and includes pharmacological, nonpharmacological, and preventive therapies (Ballas, 2002). This chapter focuses on issues relevant to the assessment and treatment of sickle cell pain in primarily pediatric populations, although some of the adult literature is reviewed, particularly as it relates to children and adolescents. SCD is a hereditary disorder. The disorder primarily affects people of Caribbean and African origin

APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Pediatric Cancer Susceptibility"

1

Chang, Vivian, Hane Lee, Tom Davidson, et al. "Abstract 08: Clinical exome sequencing in the diagnosis of pediatric cancer predisposition." In Abstracts: AACR Special Conference: Cancer Susceptibility and Cancer Susceptibility Syndromes; January 29-February 1, 2014; San Diego, CA. American Association for Cancer Research, 2014. http://dx.doi.org/10.1158/1538-7445.cansusc14-08.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Gramatges, Maria, Ninad Oak, David Wheeler, Deborah Ritter, Donna Muzny, and Sharon Plon. "Abstract 01: Genetic variation within genes related to telomere maintenance and DNA repair in a cohort of pediatric acute myeloid leukemia (AML) subjects." In Abstracts: AACR Special Conference: Cancer Susceptibility and Cancer Susceptibility Syndromes; January 29-February 1, 2014; San Diego, CA. American Association for Cancer Research, 2014. http://dx.doi.org/10.1158/1538-7445.cansusc14-01.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Plon, Sharon E., Sarah Scollon, Katie Bergstrom, et al. "Abstract 11: Evaluating cancer susceptibility mutations and incidental findings from whole exome sequencing of sequentially diagnosed pediatric solid and brain tumor patients: Early results of the BASIC3 study." In Abstracts: AACR Special Conference: Cancer Susceptibility and Cancer Susceptibility Syndromes; January 29-February 1, 2014; San Diego, CA. American Association for Cancer Research, 2014. http://dx.doi.org/10.1158/1538-7445.cansusc14-11.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Grunewald, Thomas, Marie-Ming Aynaud, Franck Tirode, et al. "Abstract A10: Functional characterization of Ewing's sarcoma susceptibility loci." In Abstracts: AACR Special Conference: Pediatric Cancer at the Crossroads: Translating Discovery into Improved Outcomes; November 3-6, 2013; San Diego, CA. American Association for Cancer Research, 2014. http://dx.doi.org/10.1158/1538-7445.pedcan-a10.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Machiela, Mitchell J., Thomas G. P. Grünewald, Didier Surdez, et al. "Abstract A13: Genome-wide association study identifies multiple new loci associated with Ewing sarcoma susceptibility." In Abstracts: AACR Special Conference: Pediatric Cancer Research: From Basic Science to the Clinic; December 3-6, 2017; Atlanta, Georgia. American Association for Cancer Research, 2018. http://dx.doi.org/10.1158/1538-7445.pedca17-a13.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!